相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Statistics on mortality following acute myocardial infarction in 842 897 Europeans
Oras A. Alabas et al.
CARDIOVASCULAR RESEARCH (2020)
Systematic investment in the delivery of guideline-coherent therapy reduces mortality and overall costs in patients with ST-elevation myocardial infarction: Results from the Stent for Life economic model for Romania, Portugal, Basque Country and Kemerovo region
Bastian Wein et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)
Patient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain-MI Registry
Benjamin A. Rodwin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
Marieke Gimbel et al.
LANCET (2020)
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project
Emanuele Barbato et al.
EUROPEAN HEART JOURNAL (2020)
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome Insights From the SWEDEHEART Registry
Karolina Szummer et al.
CIRCULATION (2020)
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With Outcomes
Christian Dworeck et al.
JAMA NETWORK OPEN (2020)
Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different P2Y12 inhibitors in a large observational study
Jeong Cheon Choe et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis
Dominick J. Angiolillo et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox
Ingo Ahrens et al.
CLINICAL CARDIOLOGY (2019)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
R. Mehran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
S. Schuepke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes: Review of the Current Evidence
Laurent Bonello et al.
CIRCULATION (2018)
Precatheterization Use of P2Y12 Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry®
Marwan Badri et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience
Diego Castini et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2017)
Long (>12 Months) and Short (<6 Months) Versus Standard Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Systematic Review and Meta-Analysis
Mohan Palla et al.
AMERICAN JOURNAL OF THERAPEUTICS (2017)
Meta-Analysis of the Relative Efficacy and Safety of Oral P2Y12 Inhibitors in Patients With Acute Coronary Syndrome
Rahman Shah et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
Matteo Vercellino et al.
BMC CARDIOVASCULAR DISORDERS (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes
Steen Husted et al.
AMERICAN JOURNAL OF THERAPEUTICS (2016)
Economic Analysis of Ticagrelor Therapy From a US Perspective
Patricia A. Cowper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention Insights Into Contemporary Practice From the National Cardiovascular Data Registry
Akshay Bagai et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results
Justyna Paweska et al.
KARDIOLOGIA POLSKA (2014)
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prasugrel vs clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a model-based cost-effectiveness analysis for Germany, Sweden, the Netherlands, and Turkey
Andrew Davies et al.
JOURNAL OF MEDICAL ECONOMICS (2013)
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan K. James et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Stefan James et al.
CIRCULATION (2010)
Timing of In-Hospital Coronary Artery Bypass Graft Surgery for Non ST-Segment Elevation Myocardial Infarction Patients Results From the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)
Shailja V. Parikh et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Comparison of ticagrelor with clopidogrel in patients with planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Christopher P. Cannon et al.
LANCET (2010)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)